Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Arin K Greene, M.D.

Co-Author

This page shows the publications co-authored by Arin Greene and David Zurakowski.
Connection Strength

1.941
  1. Greene AK, Zurakowski D, Goss JA. Body Mass Index and Lymphedema Morbidity: Comparison of Obese versus Normal-Weight Patients. Plast Reconstr Surg. 2020 08; 146(2):402-407.
    View in: PubMed
    Score: 0.246
  2. Greene AK, Zurakowski D, Goss JA. Body Mass Index and Lymphedema Morbidity: Comparison of Obese Versus Normal-Weighted Patients. Plast Reconstr Surg. 2020 Apr 27.
    View in: PubMed
    Score: 0.242
  3. Maclellan RA, Zurakowski D, Voss S, Greene AK. Correlation Between Lymphedema Disease Severity and Lymphoscintigraphic Findings: A Clinical-Radiologic Study. J Am Coll Surg. 2017 Sep; 225(3):366-370.
    View in: PubMed
    Score: 0.199
  4. Maclellan RA, Zurakowski D, Grant FD, Greene AK. Massive Localized Lymphedema: A Case-Control Study. J Am Coll Surg. 2017 Feb; 224(2):212-216.
    View in: PubMed
    Score: 0.191
  5. Couto RA, Maclellan RA, Zurakowski D, Greene AK. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg. 2012 Sep; 130(3):619-24.
    View in: PubMed
    Score: 0.142
  6. Kulungowski AM, Hassanein AH, Nosé V, Fishman SJ, Mulliken JB, Upton J, Zurakowski D, DiVasta AD, Greene AK. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012 Jun; 129(6):919e-924e.
    View in: PubMed
    Score: 0.140
  7. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012 Feb; 68(2):198-201.
    View in: PubMed
    Score: 0.137
  8. Hassanein AH, Mulliken JB, Fishman SJ, Quatrano NA, Zurakowski D, Greene AK. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012 Jan; 23(1):149-52.
    View in: PubMed
    Score: 0.136
  9. Schook CC, Mulliken JB, Fishman SJ, Grant FD, Zurakowski D, Greene AK. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011 Jun; 127(6):2419-31.
    View in: PubMed
    Score: 0.130
  10. Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010 Apr; 125(4):1185-94.
    View in: PubMed
    Score: 0.120
  11. Greene AK, Zurakowski D, Puder M, Thompson K. Determining the need for simulated training of invasive procedures. Adv Health Sci Educ Theory Pract. 2006 Feb; 11(1):41-9.
    View in: PubMed
    Score: 0.090
  12. Greene AK, Alwayn IP, Nose V, Flynn E, Sampson D, Zurakowski D, Folkman J, Puder M. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg. 2005 Jul; 242(1):140-6.
    View in: PubMed
    Score: 0.087
  13. Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV, Rialon KL, Guevara CJ, Alomari AI, Greene AK, Fishman SJ, Kozakewich HP, Maclellan RA, Mulliken JB, Rahbar R, Spencer SA, Trenor CC, Upton J, Zurakowski D, Perkins JA, Kirsh A, Bennett JT, Dobyns WB, Kurek KC, Warman ML, McCarroll SA, Murillo R. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015 Apr; 166(4):1048-54.e1-5.
    View in: PubMed
    Score: 0.042
  14. Maclellan RA, Luks VL, Vivero MP, Mulliken JB, Zurakowski D, Padwa BL, Warman ML, Greene AK, Kurek KC. PIK3CA activating mutations in facial infiltrating lipomatosis. Plast Reconstr Surg. 2014 Jan; 133(1):12e-9e.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.